CoChat

Strategies to circumvent humoral immunity to adeno-associated viral vectors

Open access
Tse, Longping V, Moller-Tank, Sven, Asokan, Aravind · 2015 · Expert Opinion on Biological Therapy

The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Recent success in gene therapy of certain monogenic diseases in the clinic has infused enthusiasm into the continued development of recombinant adeno-associated viral (AAV) vectors as next-generation biologics. However, progress in clinical trials has also highlighted the challenges posed by the host humoral immune response to AAV vectors. Specifically, while pre-existing neutralizing antibodies (NAbs) limit the cohort of eligible patients, NAb generation following treatment prevents vector re-dosing. AREAS COVERED: In this review, we discuss a spectrum of complementary strategies that can help circumvent the host humoral immune response to AAV. EXPERT OPINION: Specifically, we present a dual perspective, that is, vector versus host, and highlight the clinical attributes, potential caveats and limitations as well as complementarity associated with the various approaches.

Overview

Integrity signals

Registry

Crossref · 10.1517/14712598.2015.1035645

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 111 references

Research works printed but not linked: 6

  1. Yalkinoglu AO, 1988, Cancer Res, 48, 3123
  2. Hordeaux J, 2015, Gene Ther
  3. Carvalho LS, 2014, Mol Ther, 22, S45
  4. Gao K, 2014, Mol Ther Methods Clin Dev, 1, 20139
  5. Derksen RH, 1984, J Lab Clin Med, 104, 346
  6. Basner-Tschakarjan E, 2014, Front Immunol, 5, 28

Cited by

See all 61

Metadata

Authors
Tse, L. V., Moller-Tank, S., & Asokan, A.
Affiliations
University of North Carolina at Chapel Hill (US)
Corresponding author
Asokan, Aravind
Venue
Expert Opinion on Biological Therapy
Published
2015-05-19
Volume
15
Issue
6
Pages
845-855
ISSN
  • 1471-2598 (ISSN-L)
  • 1744-7682
OpenAlex
W1938709590
Cited by
61
References
111
Citations by year
2026: 1 · 2025: 7 · 2024: 3 · 2023: 7 · 2022: 4 · 2021: 7 · 2020: 9 · 2019: 5 · 2018: 6 · 2017: 6 · 2016: 4 · 2015: 2
FWCI
0.77
Type
journal article
Language
en
Open access
Locations
  • Expert Opinion on Biological Therapy (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • UNC Libraries
Funders
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (P01HL112761, R01HL089221)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
adeno-associated virus vectors, humoral immunity, neutralizing antibodies, gene therapy, pre-existing antibodies, AAV serotypes
MeSH terms
Dependovirus, Animals, Autoimmune Diseases, Genetic Vectors, Humans, Genetic Therapy, Immunity, Humoral, Antibodies, Neutralizing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Strategies to circumvent humoral immunity to adeno-associated viral vectors. https://app.cochat.ai/papers/10.1517/14712598.2015.1035645
The paper
Tse, L. V., Moller-Tank, S., & Asokan, A. (2015). Strategies to circumvent humoral immunity to adeno-associated viral vectors. Expert Opinion on Biological Therapy. https://doi.org/10.1517/14712598.2015.1035645

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.